BioMimetic Therapeutics Receives Orphan Drug Designation for
PipelineReview.com (press release), Spain - 57 minutes ago
Announced that it has received orphan drug designation from the Food and Drug Administration (FDA) for its protein therapeutic, recombinant human platelet
BioMimetic drug on fast track for approval Nashville Business Journal
BioMimetic drug gets orphan status BusinessWeek
all 16 news articles